Clinical Trial

Effectiveness and Acceptability of SDF Compared to ART for the Management of Early Childhood Caries

Study acronym: SDF and ART
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess the acceptability and clinical effectiveness of Silver Diamine Fluoride (SDF) in comparison with Atraumatic Restorative Treatment (ART) in Early Childhood Caries (ECC) management at the community level. The main question it aims to answer are: • It's SDF more accepted and effective than ART in early childhood caries management when implemented at the community level? Participants will be diagnosed by an experienced and calibrated dentist using the International Caries Detection and Assessment System (ICDAS), then children with decayed teeth will be treated with SDF (experimental) or ART (control); another operator will choose randomly the treatment for each participant. Furthermore, oral health education component will be given to children, parents and educators. Follow-up visits will be made at 6 and 12 months after child's treatment is complete. Before and after treatment parents will be asked to complete a child personal background survey (before), Early Childhood Oral Health Impact Scale (ECOHIS) questionnaire (before and at follow-ups) and a oral health satisfaction survey (one week after treatment and at follow-ups). The acceptability will be assessed through quantitative and qualitative methods. Researchers will compare the SDF's groups and the ART's group to see which of them is more accepted and effective.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-15; most recent amendment 2025-12-04.
Trial Details
NCT Number NCT06786975
Lead Sponsor Universidad de La Frontera
Conditions Early Childhood Caries, Health Care Acceptability
Enrollment 156 participants
Start Date 2025-12-15
Primary Completion 2026-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-12